Mielodiszplasztikus szindróma (MDS): vizsgálatok itt: Belgium
12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in BelgiumStudy comparing thymoglobulin to grafalon, two treatments used to prevent graft versus host disease in elderly patients with acute myeloid leukemia or myelodysplastic syndrome and receiving an allogeneic stem cell transplantation with an unrelated matched donor after a reduced intensity conditioning regimen
- Where
- Sint-Lambrechts-Woluwe
- Életkor
- 18 év and over
- People
- 334 worldwide
- Run by
- Assistance Publique Hopitaux De Paris
See details and how to join2023-504555-27-00 - 3. fázisTaking peoplePhase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2
- Where
- Antwerp, Brugge, Brussel, Leuven, Roeselare, Yvoir
- Életkor
- 18 év to 75 év
- People
- 650 worldwide
- Run by
- University of Ulm
See details and how to joinNCT04628026 · EU 2023-507518-28-00 - 1. fázisTaking peopleA Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
- Where
- Edegem, Gent, Leuven
- People
- 225 worldwide
- Run by
- Janssen Cilag International
See details and how to join2026-525234-39-00 - 3. fázisTaking peopleA Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
- Where
- Leuven, Roeselare, Yvoir
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Takeda
See details and how to joinNCT07422480 · EU 2025-523544-12-00 - 1. fázisTaking peopleA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Gent
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - 1. fázisTaking peopleSafety and Tolerability of REGN17235 in Adult Participants With Clonal Cytopenia of Undetermined Significance and Low-Risk Myelodysplastic Syndrome With SF3B1 Mutation
- Where
- Antwerp, Gent, Leuven, Roeselare
- Életkor
- 18 év and over
- People
- 52
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07753148 · EU 2026-525464-18-00 - 3. fázisTaking peopleLisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
- Where
- Antwerp, Brasschaat, Brugge, Gent, Leuven, Roeselare
- Életkor
- 18 év and over
- People
- 490 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06641414 · EU 2024-517247-31-00 - 2. fázisVisszavonva(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Liège
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00 - 3. fázisBefejeződöttA Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Where
- Brasschaat, Bruges, Ghent, Leuven
- Életkor
- 18 év and over
- People
- 665 worldwide
- Run by
- Celgene
See details and how to joinNCT04064060 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Antwerp, Ghent, Leuven, Roeselare
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - 2. fázisTaking peopleAllogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning
- Where
- Anderlecht, Antwerp, Brugge, Gent, Jette, Leuven, Roeselare, Sint-Lambrechts-Woluwe, Yvoir
- Életkor
- 18 év to 75 év
- People
- 114
- Run by
- University of Liege
See details and how to joinNCT03852407 · EU 2024-518568-11-00 - 1. fázisTaking peopleStudy in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02
- Where
- Leuven, Liège, Roeselare
- Életkor
- 18 év and over
- People
- 27 worldwide
- Run by
- Celyad Oncology SA
See details and how to joinNCT04167696